Cell based assays market will expand at a healthy CAGR of 7.7% during the forecast period of 2017 to 2022
Request to View Sample Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=846
As per the projections of the TMR report, the demand in the global cell based assays market will expand at a healthy CAGR of 7.7% during the forecast period of 2017 to 2022. The revenue in the market for cell based assays, across the world, is estimated to be worth US$19,710.7 mn by 2022, substantially up from its evaluated valuation of US$13,576.7 mn in 2017. In the near future, most of the leading companies of this market are expected to invest on research and development in order to stay ahead of the curve. They are also expected to focus on emerging economies in Asia Pacific to gain market shares as well as indulge in collaborations and mergers.
Based on product-type, the global cell based assays market gains maximum demand for reagents and consumables, a segment that constituted 32.1% of the total demand in 2017 and produced a revenue of US$4,356.6 mn the same year. The demand for reagents and consumables segment of the cell based assays market has been anticipated to increment at a CAGR of 7.5% during the forecast period of 2017 to 2022. Geographically, the TMR report picks out North America as the most lucrative region, which is projected to exhibit an above-average CAGR of 7.5% during the said forecast period. North America cell based assays market is estimated to be worth US$7,672.5 mn by 2022.Global Cell Based Assays Market.jpgIncremented Investments for R&D and Government Support Driving Demand
The growing prevalence of chronic diseases such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, increased availability of funding for research along with government support, incrementing preference for cell-based assays, and increasing drug discovery activity are some of the key factors augmenting the demand in the global cell based assays market. Cell based assays can be of various types, ranging from cytotoxic assays to cell proliferation, and are used to check drug stability, drug potency, and drug purification, as well as in production support. Cell based assays are primarily used by companies operating in the fields of pharmaceutical and biotechnology and has numerous possibilities for the future, promising to revolutionize the therapeutics of life-threatening diseases such as cancer and immunology. The global cell based assays market is also gaining traction from the emergence of novel technologies in science and medicine. For example, Symcel, the company who developed calScreener - a cell based assay tool for real-time cellular bioenergetic measurements, recently associated with Colzyx, working together on a goal to identify and test 25 different new collagen VI derived antimicrobial peptides. These recently discovered peptides are first of its kind and may be able to kill bacterial growth in different ways.
Read Report Overview @ https://www.transparencymarketresearch.com/cell-based-assays.html
Growing adoption of cell assay based high-throughput screening methods of drug compound screening, replacement of in vivo toxicity testing by in vitro testing methods, and emergence of new branches in bio-science such as synthetic biology, which depends on accurate cell testing, are some of the other factors that will ensure a healthy future growth of the cell based assay market. On the other hand, high cost of instruments and restrictions pertaining to the usage of reagents are challenging the cell based assays market from attaining its true potential.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell based assays market will expand at a healthy CAGR of 7.7% during the forecast period of 2017 to 2022 here
News-ID: 844697 • Views: 121
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for Cell
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Global Cell Therapy Market & Cell Therapy Clinical Pipeline Outlook 2022
The cell therapy industry is rapidly growing industry with the several new products that having been accepted for clinical use over the past few years. There are many challenges that need to be resolved wisely before the cell therapies are widely accepted, including the optimization of their manufacture. There is much to be explored about the specific features of the stem cells and about the efficacy and safety of the
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of